Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 27 matching records.
27 results — page 1 of 2
- Level DAnimal StudyPubMed
A Novel Peroxisome Proliferator-Activated Receptor Gamma/Nuclear Factor-Kappa B Activation Pathway is Involved in the Protective Effect of Adipose-Derived Mesenchymal Stem Cells Against Ischemia-Reperfusion Lung Injury.
Animal Study, published in Transplant Proc (2024) — summary generated from the PubMed abstract.
- 2024
Transplant Proc - Level DAnimal StudyPubMed
Foxk1 stimulates adipogenic differentiation via a peroxisome proliferator-activated receptor gamma 2-dependent mechanism.
Animal Study, published in FASEB J (2023) — summary generated from the PubMed abstract.
- 2023
FASEB J - Level DNarrative ReviewPubMed
The MicroRNA-signaling-peroxisome proliferator-activated receptor gamma connection in the modulation of adipogenesis: bioinformatics projection on chicken.
Narrative Review, published in Poult Sci (2022) — summary generated from the PubMed abstract.
- 2022
Poult Sci11 citations - Level DAnimal StudyEurope PMC
A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice
Animal Study on Type 2 Diabetes, published in Mol Metab (2021) — summary generated from the PubMed abstract.
- 2021
Mol Metab20 citations - Level DLaboratory StudyEurope PMC
Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover
Laboratory Study on Type 2 Diabetes, published in Adipocyte (2018) — summary generated from the PubMed abstract.
- 2018
Adipocyte5 citations - Level DLaboratory StudyPubMed
Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma.
Laboratory Study on Chronic Inflammation, published in Genes Nutr (2013) — summary generated from the PubMed abstract.
- 2013
Genes Nutr20 citations - Level DAnimal StudyPubMed
Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.
Animal Study, published in J Biol Chem (2011) — summary generated from the PubMed abstract.
- 2011
J Biol Chem94 citations - Level DAnimal StudyEurope PMC
A peroxisome proliferator-activated receptor gamma (PPARgamma)/PPARgamma coactivator 1beta autoregulatory loop in adipocyte mitochondrial function
Animal Study, published in J Biol Chem (2011) — summary generated from the PubMed abstract.
- 2011
J Biol Chem26 citations - Level DAnimal StudyEurope PMC
Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages
Animal Study on Chronic Inflammation, published in FEBS J (2010) — summary generated from the PubMed abstract.
- 2010
FEBS J21 citations - Level DAnimal StudyPubMed
miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression.
Animal Study, published in Mol Cell Biol (2010) — summary generated from the PubMed abstract.
- 2010
Mol Cell Biol - Level DAnimal StudyPubMed
Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
Animal Study on Systemic / IV, published in Am J Pathol (2009) — summary generated from the PubMed abstract.
- 2009
Am J Pathol - Level CProspective StudyEurope PMC
Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81)
Prospective Study on Type 2 Diabetes, published in J Biol Chem (2009) — summary generated from the PubMed abstract.
- 2009
J Biol Chem70 citations - Level DAnimal StudyPubMed
Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor.
Animal Study on Hip, Systemic / IV, published in Am J Physiol Endocrinol Metab (2009) — summary generated from the PubMed abstract.
- 2009
Am J Physiol Endocrinol Metab - Level DAnimal StudyPubMed
The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma.
Animal Study on Face & Skin, Systemic / IV, published in Mol Endocrinol (2008) — summary generated from the PubMed abstract.
- 2008
Mol Endocrinol - Level DAnimal StudyPubMed
Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis.
Animal Study, published in Endocrinology (2007) — summary generated from the PubMed abstract.
- 2007
Endocrinology - Level DAnimal StudyPubMed
JTP-426467 acts as a selective antagonist for peroxisome proliferator-activated receptor gamma in vitro and in vivo.
Animal Study on Hip, published in Diabetes Obes Metab (2006) — summary generated from the PubMed abstract.
- 2006
Diabetes Obes Metab20 citations - Level CProspective StudyPubMed
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.
Prospective Study, published in Endocrinology (2006) — summary generated from the PubMed abstract.
- 2006
Endocrinology - Level CCase Report / SeriesPubMed
Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?
Case Report / Series on Autoimmune Research, published in J Clin Endocrinol Metab (2003) — summary generated from the PubMed abstract.
- 2003
J Clin Endocrinol Metab - Level DAnimal StudyPubMed
Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.
Animal Study on Hip, published in Biochem J (2003) — summary generated from the PubMed abstract.
- 2003
Biochem J - Level CProspective StudyPubMed
Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.
Prospective Study, published in J Clin Endocrinol Metab (2002) — summary generated from the PubMed abstract.
- 2002
J Clin Endocrinol Metab - Level DAnimal StudyPubMed
Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.
Animal Study, published in Endocrinology (2002) — summary generated from the PubMed abstract.
- 2002
Endocrinology - Level DAnimal StudyPubMed
The expression of peroxisome proliferator-activated receptor gamma in pig fetal tissue and primary stromal-vascular cultures.
Animal Study, published in Obes Res (2000) — summary generated from the PubMed abstract.
- 2000
Obes Res - Level DAnimal StudyPubMed
Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Animal Study on Hip, published in Cancer Res (2000) — summary generated from the PubMed abstract.
- 2000
Cancer Res - Level DAnimal StudyPubMed
Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation.
Animal Study, published in J Biol Chem (1997) — summary generated from the PubMed abstract.
- 1997
J Biol Chem
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406